Sarken STAT! Multi-Drug Test Panel Recalled for Inadequate Labeling
Sarken, Inc. is recalling STAT! Multi-Drug Test Panels because they were distributed without adequate labeling and instructions for use, which could lead to misuse and incorrect test results.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text explicitly states that the hazard is theoretical (potential for misuse and incorrect results) and does not report any illnesses, injuries, or deaths. Per the rubric, a theoretical hazard with no reported harm is capped at a score of 3, but given the nature of a labeling defect without immediate physical danger, it aligns with Moderate severity.
Plain-English summary
Sarken, Inc. is recalling the SARKEN STAT! Multi-Drug Test Panel. The product is labeled as "FOR FORENSIC USE ONLY (Employee, Student or Probation Testing)". The recall involves various quantities of the product, specifically Manufacturer's Product Number HMO-W264, Lot Number F2290966, with an expiration date of 02/2014.
The products are being recalled because they were distributed without adequate labeling and instructions for use. The FDA notes that inadequate labeling could lead to misuse of the test kits and incorrect test results.
The product was distributed worldwide and nationwide in the United States, including the Virgin Islands. Consumers and users should stop using the affected test panels and contact Sarken, Inc. for further instructions or a refund.
The recalled product
- Product
- SARKEN STAT! Multi-Drug Test Panel Product Usage- Labeled as FOR FORENSIC USE ONLY (Employee, Student or Probation Testing).
- Manufacturer
- Sarken, Inc.
Distribution
Part of a larger recall action
This product is one of 6 recalled by Sarken, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Sarken, Inc.
See all →- ModerateSarken STAT! 1-Panel Test Kit Recalled for Inadequate Labeling
FDA (Devices) · 2013-09-04
- ModerateSarken STAT! Multi-Drug Test Panel Recalled for Inadequate Labeling
FDA (Devices) · 2013-09-04
- ModerateSarken THC Test Kits Recalled for Inadequate Labeling and Instructions
FDA (Devices) · 2013-09-04
- ModerateSarken STAT! 1-Panel Test Kit Recalled for Inadequate Labeling
FDA (Devices) · 2013-09-04
- ModerateSarken STAT! 1-Panel Test Kit Recalled for Inadequate Labeling
FDA (Devices) · 2013-09-04
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- LowStat Rx USA Recalls Methocarbamol Tablets Due to Incorrect Expiration Date
FDA (Drugs) · 2013-02-13
- ModerateLumiQuick Drugs of Abuse Panel Test Device Recalled for Regulatory Violations
FDA (Devices) · 2014-04-16
- ModerateAmeditech Fastect II Drug Screen Dipstick Tests Recalled for Performance Failures
FDA (Devices) · 2020-10-07
- HighNystatin Powder Recall Due to Incorrect Assay Strength on Label
FDA (Drugs) · 2023-12-27
- LowFagron Recalls Zinc Oxide Paste Due to Labeling Error
FDA (Drugs) · 2017-05-10
- SevereAidapak Recalls Digoxin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29